Blood cancers, Myeloma
Open
Phase 1
This trial is looking at adding a drug called belantamab mafodotin to usual treatment for myeloma.
It is for people whose myeloma has come back or treatment has stopped working.
Recruitment start: 11 May 2022
Recruitment end: 1 December 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rakesh Popat
GlaxoSmithKline Ltd
UKMRA-Myeloma UK-CARP
Last reviewed: 29 August 2025
CRUK internal database number: 15440
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
